In recent years, the role of the microbiome has been revolutionizing our understanding of chronic disease—and eye health is no exception. While traditionally overlooked by many eye care providers, emerging research is showing us that dysbiosis—an imbalance in the gut microbiota—can be a significant contributor to serious ocular conditions such as autoimmune uveitis and age-related macular degeneration (AMD).
Our gut is home to trillions of microorganisms that influence digestion, nutrient absorption, immune function, and even neurological signaling [5]. It turns out these same microbes also have an impact on immune privilege and inflammation in the eye. Studies in both humans and animal models have illustrated clear differences in microbiome composition between individuals with inflammatory or degenerative eye disease and healthy controls [2][10].
In uveitis, a form of ocular inflammation, the connection is especially strong in patients with autoimmune conditions like inflammatory bowel disease. Research by Horai et al. [4] and Nakamura et al. [7] demonstrated that gut bacteria can activate retina-specific T-cells in the intestine, which later trigger inflammation in the eye—even without prior intraocular exposure. These groundbreaking findings suggest that modifying the gut microbiome through dietary intervention or targeted treatment could one day prevent or modulate uveitis [9].
In AMD, obesity-driven gut dysbiosis appears to influence pathologic neovascularization in the retina. Andriessen et al. [2] and Zinkernagel et al. [10] revealed changes in bacterial ratios, inflammatory markers, and microbial metabolic function in patients with neovascular AMD. Fecal transplants from healthy mice even reversed some AMD pathology in animal models.
The potential for microbiome modulation to reshape ocular outcomes is immense. Whether through diet, prebiotics, probiotics, or future therapeutics, eye care professionals have a responsibility to stay abreast of this shifting paradigm. With initiatives like the Human Microbiome Project [6] and growing interest in the ocular microbiome [1][6], the future may offer precision nutrition and gut-based interventions as part of standard care.
Emerging research has also begun to explore the unique ecosystem of the eye itself. The ocular microbiome—distinct from the gut—includes a variety of bacterial species found on the cornea and conjunctiva, with Pseudomonas, Acinetobacter, and Corynebacterium among the most prevalent [1]. This niche may also influence conditions like dry eye syndrome or contact lens complications and offers yet another area ripe for exploration.
As someone who bridges functional medicine and optometry, my goal is to keep driving awareness and research on the profound impact of the gut–eye connection. We are just beginning to see the possibilities. Encouragingly, recent evidence from Bian et al. [3] shows that a diverse and healthy gut microbiota can be preserved into advanced age, which may offer protective effects even into the tenth decade of life.
Let’s ensure eye care stays on the frontier of integrative science—because the future of vision health may very well start in the gut.
Key References:
1. Abelson, M.B., Lane, K., Slocum, C. (2015). The secrets of ocular microbiomes. Review of Ophthalmology. https://www.reviewofophthalmology.com/article/the-secrets-of-ocular-microbiomes
2. Andriessen, E. et al. (2016). Gut microbiota influences pathological angiogenesis in obesity-driven choroidal neovascularization. EMBO Molecular Medicine, 8(12), 1366–1379. https://doi.org/10.15252/emmm.201606531
3. Bian, G. et al. (2017). The gut microbiota of healthy aged Chinese is similar to that of the healthy young. mSphere, 2:e00327-17. https://doi.org/10.1128/mSphere.00327-17
4. Horai, R. et al. (2015). Microbiota-dependent activation of an autoreactive T cell receptor provokes autoimmunity in an immunologically privileged site. Immunity, 43(2), 343–353. https://doi.org/10.1016/j.immuni.2015.07.014
5. Jandhyala, S.M. et al. (2015). Role of the normal gut microbiota. World Journal of Gastroenterology, 21(29), 8787–8803. https://doi.org/10.3748/wjg.v21.i29.8787
6. Lu, L.J., Liu, J. (2016). Human microbiota and ophthalmic disease. Yale Journal of Biology and Medicine, 89, 325–330.
7. Nakamura, N.K. et al. (2016). Gut microbial alterations associated with protection from autoimmune uveitis. IOVS, 57(8), 3747–3758. https://doi.org/10.1167/iovs.16-19733
8. Quigley, E.M.M. (2013). Gut bacteria in health and disease. Gastroenterology & Hepatology, 9(9), 560–569.
9. Rosenbaum, J.T. et al. (2016). Does the microbiome cause B27-related acute anterior uveitis? Ocular Immunology and Inflammation, 24(4), 440–444. https://doi.org/10.3109/09273948.2016.1142574
10. Zinkernagel, M.S. et al. (2017). Association of the intestinal microbiome with the development of neovascular AMD. Scientific Reports, 7, 40826. https://www.nature.com/articles/srep40826
